Apnimed to Participate in the William Blair Virtual Conference: Transitioning Biotech Breakthroughs to Commercial Success
CAMBRIDGE, Mass., July 12, 2023 (GLOBE NEWSWIRE) — Apnimed, Inc., a clinical-stage pharmaceutical company focused…
News
LianBio Announces Clinical Supply Agreement with AstraZeneca in China to Evaluate BBP-398 in Combination with Osimertinib in Patients with Non-Small Cell Lung Cancer with EGFR Mutations
SHANGHAI, China and PRINCETON, N.J., July 12, 2023 (GLOBE NEWSWIRE) — LianBio (Nasdaq: LIAN), a…
LianBio Announces Clinical Supply Agreement with AstraZeneca in China to Evaluate BBP-398 in Combination with Osimertinib in Patients with Non-Small Cell Lung Cancer with EGFR Mutations
SHANGHAI, China and PRINCETON, N.J., July 12, 2023 (GLOBE NEWSWIRE) — LianBio (Nasdaq: LIAN), a…
Aridis’ AR-301 Monoclonal Antibody is Among the First Biologics to Receive FDA’s Qualified Infectious Diseases Product (QIDP) Designation
QIDP designation for Biologics provides FDA Priority Review status LOS GATOS, Calif., July 12, 2023…
Aridis’ AR-301 Monoclonal Antibody is Among the First Biologics to Receive FDA’s Qualified Infectious Diseases Product (QIDP) Designation
QIDP designation for Biologics provides FDA Priority Review status LOS GATOS, Calif., July 12, 2023…
Lumos Pharma to Participate in the Oppenheimer 2023 Montauk Life Sciences Summit
AUSTIN, Texas, July 12, 2023 (GLOBE NEWSWIRE) — Lumos Pharma, Inc. (NASDAQ:LUMO), a biopharmaceutical company advancing…
Lumos Pharma to Participate in the Oppenheimer 2023 Montauk Life Sciences Summit
AUSTIN, Texas, July 12, 2023 (GLOBE NEWSWIRE) — Lumos Pharma, Inc. (NASDAQ:LUMO), a biopharmaceutical company advancing…
Ocular Therapeutix™ Announces Appointment of New Board Member
Dr. Adrienne Graves to join Board of Directors BEDFORD, Mass., July 12, 2023 (GLOBE NEWSWIRE)…
Ocular Therapeutix™ Announces Appointment of New Board Member
Dr. Adrienne Graves to join Board of Directors BEDFORD, Mass., July 12, 2023 (GLOBE NEWSWIRE)…
INmune Bio Inc. to Deliver Keynote Talk at 5th World Aging and Rejuvenation Conference.
RJ Tesi MD, CEO of INmune Bio, to Present Opening Keynote on Drug Development Strategies…
INmune Bio Inc. to Deliver Keynote Talk at 5th World Aging and Rejuvenation Conference.
RJ Tesi MD, CEO of INmune Bio, to Present Opening Keynote on Drug Development Strategies…
Slynd® (drospirenone) is now covered by the Régie de l’assurance maladie du Québec
Slynd® Slynd® is now reimbursed for 100% of Quebec women to whom it is indicated….
Slynd® (drospirenone) is now covered by the Régie de l’assurance maladie du Québec
Slynd® Slynd® is now reimbursed for 100% of Quebec women to whom it is indicated….
CENTOGENE Biodatabank Reveals Unique Genetic Variants in World’s Largest Niemann-Pick Type C1 Disease Cohort
Results Published in European Journal of Human Genetics Demonstrate Unprecedented Insights to Accelerate Potential Treatment…
CENTOGENE Biodatabank Reveals Unique Genetic Variants in World’s Largest Niemann-Pick Type C1 Disease Cohort
Results Published in European Journal of Human Genetics Demonstrate Unprecedented Insights to Accelerate Potential Treatment…
RIFF Cannabis Brand Launches New THC Beverages for Summer
New RIFF Wild Raspberry Lemonade and RIFF Blue Raspberry Ice Sparkling Drinks Infused with 10mg…
RIFF Cannabis Brand Launches New THC Beverages for Summer
New RIFF Wild Raspberry Lemonade and RIFF Blue Raspberry Ice Sparkling Drinks Infused with 10mg…
Arbutus Appoints Melissa V. Rewolinski, PhD to its Board of Directors
WARMINSTER, Pa., July 12, 2023 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or…
Arbutus Appoints Melissa V. Rewolinski, PhD to its Board of Directors
WARMINSTER, Pa., July 12, 2023 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or…
Evelo Biosciences Closes $25.5 Million Private Placement
Restructures and reduces secured debt with Horizon Technology Finance Corporation Appoints two new members and…